Neurol. praxi. 2010;11(2):112-116

Speech disorders in Parkinson’s disease

Mgr.Gabriela Zamišková1, MUDr.Pavel Ressner, Ph.D.1, Mgr.Jana Dlouhá1, Dana Šigutová2
1 Neurologické oddělení, NsP v Novém Jičíně
2 Oddělení následné péče Vítkov, detašované pracoviště NsP v Novém Jičíně

The issues of speech disorders in Parkinson’s disease (PD) are discussed. The characteristic symptomatology in individual speech areas

accompanying hypokinetic dysarthria (HD) is mainly dealt with. The symptomatology of HD is classified in terms of respiration, phonation,

and facial musculature. The diagnostic and therapeutic procedures used in speech and language therapy are mentioned which are suitable

in patients with PD and reported in the foreign literature as well as, and in particular, those used in our conditions. The Lee Silverman Voice

Treatment (LSVT) method is dealt with in detail. Diagnosis and therapy of speech disorders is an integral part of a complex approach in PD

treatment and may significantly improve the life and self-sufficiency of persons with PD. A lot of the symptoms of speech and communication

disorders are common in Parkinson’s disease and a number of PD patients have an impaired quality of life due to impaired communication

with others; still, only a small number of persons see a speech therapist for these complaints.

Keywords: Parkinson’s disease, speech disorders, hypokinetic dysarthria, Lee Silverman Voice Treatment

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zamišková G, Ressner P, Dlouhá J, Šigutová D. Speech disorders in Parkinson’s disease. Neurol. praxi. 2010;11(2):112-116.
Download citation

References

  1. Bachurová H, Housarová H. Komunikace a řeč osob s PN. Parkinson - časopis společnosti Parkinson 2005; 17: 14.
  2. Růžičková H. Poruchy hlasu, řeči a komunikace u Parkinsonovy nemoci. In Roth J, Sekyrová M, Růžička E, et al. Parkinsonova nemoc. 4. vyd. Praha: Maxdorf 2009: 107-121.
  3. Burianová K, Zdařilová E, Mayer M, Ošťádal O. Poruchy dýchání u neurologicky nemocných. Neurol. pro praxi 2006; 1: 46-48.
  4. Dvořák J. Logopedický slovník terminologický a výkladový. Žďár nad Sázavou: Logopedické centrum 2001: 221.
  5. Hedánek J, Roubíčková J. Test 3F - Dysartrický profil. Praha: DeskTop Publishing FF UK 1997: 104.
  6. Košťálová M, Bednařík J, Mechl M, Voháňka S, Šnábl I. Multimediální výukový atlas poruch řeči a příbuzných kognitivních funkcí. Brno: Masarykova univerzita 2004: 128.
  7. Logemann JA, Fisher HB. Vocal tract control in Parkinson´s Disease. Journal of Speech and Hearing Disorders 1981; 46: 348-352. Go to original source... Go to PubMed...
  8. Love RJ, Webb WG. Mozek a řeč. Praha: Portál 2009: 372.
  9. National Collaborating Centre for Chronic Conditions. Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. London (UK): Royal College of Physicians 2006: 237.
  10. Neubauer K, et al. Neurogenní poruchy komunikace u dospělých. Praha: Portál 2007: 227.
  11. Pentland B, Pitcairn TK, Gray JM, Riddle W, jr. The effects of reduced expression in Parkinson's disease on impression formation by health Professionals. Clinical Rehabilitation 1987; 1: 307-312. Go to original source...
  12. Ramig LO, Fox C, Sapir S. Speech treatment for Parkinson´s Disease. Expert Review of Neurotherapeutics 2008; 8: 297-309. Go to original source... Go to PubMed...
  13. Růžička E, Roth J, Kaňovský P, Sekyrová M, Vrgošík D, Vladyka V. Parkinsonova nemoc a parkinsonské syndromy. Praha: Galén 2000: 293.
  14. Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson disease. Current Opinion in Otolaryngology and Head and Neck Surgery 2008; 16: 205-210. Go to original source... Go to PubMed...
  15. Sharkawi A, Raming L, Logemann JA, Pauloski BR, Rademaker AW, Smith CH, Pawlas A, Baum S, Werner C. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. Journal of Neurology, Neurosurgery and Psychiatry 2002; 72: 31-36. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.